Altimmune, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Altimmune, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Altimmune, Inc. Return On Equity for the quarter ending September 30, 2024 was -63.4 %, a 35.6% decline year-over-year.
  • Altimmune, Inc. annual Return On Equity for 2023 was -52 %, a 18.2% decline from 2022.
  • Altimmune, Inc. annual Return On Equity for 2022 was -44 %, a 1.57% decline from 2021.
  • Altimmune, Inc. annual Return On Equity for 2021 was -43.3 %, a 20.8% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52 -8.01 -18.2% Jan 1, 2023 Dec 31, 2023
2022 -44 -0.68 -1.57% Jan 1, 2022 Dec 31, 2022
2021 -43.3 -7.47 -20.8% Jan 1, 2021 Dec 31, 2021
2020 -35.9 +3.14 +8.05% Jan 1, 2020 Dec 31, 2020
2019 -39 +56.3 +59.1% Jan 1, 2019 Dec 31, 2019
2018 -95.3 +0.73 +0.76% Jan 1, 2018 Dec 31, 2018
2017 -96.1 -74.8 -352% Jan 1, 2017 Dec 31, 2017
2016 -21.3 -7.39 -53.2% Jan 1, 2016 Dec 31, 2016
2015 -13.9 +57.8 +80.6% Jan 1, 2015 Dec 31, 2015
2014 -71.7 +40.3 +36% Jan 1, 2014 Dec 31, 2014
2013 -112 -73.8 -193% Jan 1, 2013 Dec 31, 2013
2012 -38.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.